Schizophrenia Clinical Trials

20 trials recruiting in Canada.

Mental Health

Recruiting Drug Device Behavioral Older adults Healthy volunteers

5 trials

Testing KarXT against a placebo for psychosis associated with Alzheimer's disease

Explore this study →

There are 2 groups in this study. Group A receives KarXT. Group B, the placebo group, receives Placebo.

Sites in Calgary, Hamilton and 4 more cities

Phase 3
2 groups
Sites in Calgary, Hamilton and 4 more cities
Recruiting

Official title: A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

Psychosis Associated With Alzheimer's Disease · Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Testing KarXT for psychosis associated with Alzheimer's disease

Explore this study →

Everyone in this study is in one group and receives KarXT.

Sites in Calgary, Hamilton and 3 more cities

Phase 3
1 group
Sites in Calgary, Hamilton and 3 more cities
Recruiting

Official title: Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Psychosis Associated With Alzheimer's Disease · Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Testing ML-007C-MA against a placebo for psychosis associated with Alzheimer's disease

Explore this study →

There are 2 groups in this study. Group A receives ML-007C-MA. Group B, the placebo group, receives Placebo.

Sites in Brampton, Lévis and 2 more cities

Phase 2
2 groups
Sites in Brampton, London and 2 more cities
Recruiting

Official title: A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Psychosis Associated With Alzheimer's Disease · MapLight Therapeutics

Get matched to the best-fit trials

Answer a few questions and we'll find the closest matches for schizophrenia.

Testing Clozapine for schizophrenia

Explore this study →

There are 2 groups in this study. Group A receives Clozapine. Group B receives no study treatment and is followed for comparison.

One site, in Toronto

Phase 4
2 groups
One site, in Toronto
Recruiting

Official title: Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

Schizophrenia · Centre for Addiction and Mental Health

Testing Risperidone with Olanzapine for schizophrenia and related disorders

Explore this study →

There are 2 groups in this study. Group A receives one or more of: Risperidone, Olanzapine and paliperidone. Group B receives no study treatment and is followed for comparison.

One site, in Toronto

Phase 4
2 groups
One site, in Toronto
Recruiting

Official title: "Extended" (Alternate Day) Antipsychotic Dosing

Schizophrenia and Related Disorders · Centre for Addiction and Mental Health

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Schizophrenia trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.